Brief: Biofrontera Inc. Closes Purchase of All Ameluz and RhodoLED US Assets from Biofrontera AG
23/10/2025 13:49
Oct 23 (Reuters) - Biofrontera Inc BFRI.O: BIOFRONTERA INC - EXPECTS FULL TRANSFER OF ASSETS AND PERSONNEL TO BE COMPLETED BY LATE Q4 2025 OR EARLY Q1 2026 Source text: ID:nGNXbph1xp Further company coverage: BFRI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales